Scancell Holdings (GB:SCLP) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Scancell Holdings plc, a developer of cancer immunotherapies, has appointed Dr. Florian Reinaud as a Non-Executive Director to its Board. With over two decades of experience in the healthcare sector, Reinaud’s extensive background spans executive roles, investment expertise, and a medical career, including his current position at Redmile Group, an investment firm focused on healthcare. His appointment is expected to bring considerable value to Scancell as it progresses its lead assets through advanced clinical trials.
For further insights into GB:SCLP stock, check out TipRanks’ Stock Analysis page.